TY - JOUR
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Longitudinal Studies
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Stress Disorders, Post-Traumatic/drug therapy
KW - Vermont
KW - buprenorphine
KW - interim treatment
KW - opioid use disorder
KW - Posttraumatic stress disorder
KW - rurality
AU - K. R. Peck
AU - N. Moxley-Kelly
AU - G. J. Badger
AU - S. C. Sigmon
A1 - 
AD - The Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA. Electronic address: kelly.peck@uvm.edu.; The Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA. Electronic address: nathaniel.moxley-kelly@uvm.edu.; Department of Medical Biostatistics, University of Vermont, Burlington, VT, USA. Electronic address: gary.badger@uvm.edu.; The Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA. Electronic address: stacey.sigmon@uvm.edu.
BT - Preventive medicine
C5 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
CP - Pt 2
DO - 10.1016/j.ypmed.2021.106817
IS - Pt 2
JF - Preventive medicine
LA - eng
M1 - Journal Article
PB - . Published by Elsevier Inc
PY - 2021
SN - 1096-0260; 0091-7435; 0091-7435
SP - 106817
T1 - Posttraumatic stress disorder in individuals seeking treatment for opioid use disorder in Vermont
T2 - Preventive medicine
TI - Posttraumatic stress disorder in individuals seeking treatment for opioid use disorder in Vermont
U1 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
U2 - 34599919
U3 - 10.1016/j.ypmed.2021.106817
VL - 152
VO - 1096-0260; 0091-7435; 0091-7435
Y1 - 2021
Y2 - Nov
ER -